Bespoke Extracts, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bespoke Extracts, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.12M | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | $785.5K | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.4K | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | $4.6K | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | $35.6K | Apr 27, 2023 |
| FY2019 | Aug 31, 2019 | $62.1K | Dec 16, 2019 |
| FY2019 | Aug 31, 2018 | $15.9K | Dec 16, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $452.9K | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | $343.2K | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.3K | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | $2.6K | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | $22.0K | Apr 27, 2023 |
| FY2021 | Aug 31, 2020 | $4.5K | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | ($9.3K) | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | ($7.0K) | Dec 16, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.04M) | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | ($1.48M) | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | ($4.12M) | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | ($25.3K) | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | ($965.6K) | Apr 27, 2023 |
| FY2021 | Aug 31, 2020 | ($4.64M) | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | $2.58M | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | ($7.61M) | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | ($6.68M) | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | ($365.0K) | Dec 21, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($994.6K) | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | ($1.47M) | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | ($4.02M) | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | ($319.8K) | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | ($965.6K) | Apr 27, 2023 |
| FY2021 | Aug 31, 2020 | ($4.02M) | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | $3.01M | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | ($7.19M) | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | ($6.62M) | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | ($364.6K) | Dec 21, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.28M | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | $1.59M | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.74M | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | $215.3K | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | $640.9K | Apr 27, 2023 |
| FY2019 | Aug 31, 2019 | ($3.51M) | Dec 16, 2019 |
| FY2019 | Aug 31, 2018 | $6.77M | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | $6.33M | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | $34.5K | Dec 21, 2017 |
| FY2016 | Aug 31, 2015 | $30.6K | Feb 8, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($289.8K) | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | ($415.2K) | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | ($798.1K) | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | ($105.4K) | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | ($1.04M) | Apr 27, 2023 |
| FY2021 | Aug 31, 2020 | ($465.2K) | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | ($492.7K) | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | ($747.7K) | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | ($422.1K) | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | ($216.9K) | Dec 21, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $600.0K | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | $7.2K | Apr 18, 2024 |
| FY2022 | Aug 31, 2021 | $2.7K | Apr 27, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $359.1K | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | $354.4K | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | $409.6K | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | $2.49M | Apr 27, 2023 |
| FY2021 | Aug 31, 2021 | $124.5K | Dec 13, 2021 |
| FY2021 | Aug 31, 2020 | $166.2K | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | $79.4K | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | $219.8K | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | $155.6K | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | $1.7K | Dec 21, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.45M | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | $2.08M | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.08M | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | $500.4K | Apr 27, 2023 |
| FY2019 | Aug 31, 2019 | $111.1K | Dec 16, 2019 |
| FY2019 | Aug 31, 2018 | $647.3K | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | $427.7K | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | $115.5K | Dec 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($2.09M) | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | ($1.72M) | Apr 21, 2025 |
| FY2024 | Dec 31, 2022 | ($672.1K) | Apr 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.99M | Apr 18, 2024 |
| FY2022 | Aug 31, 2021 | ($418.2K) | Apr 27, 2023 |
| FY2022 | Aug 31, 2020 | ($513.7K) | Apr 27, 2023 |
| FY2021 | Aug 31, 2019 | ($31.6K) | Dec 13, 2021 |
| FY2020 | Aug 31, 2018 | ($427.5K) | Dec 18, 2020 |
| FY2019 | Aug 31, 2017 | ($272.1K) | Dec 16, 2019 |
| FY2018 | Aug 31, 2016 | ($113.8K) | Dec 14, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($26.40M) | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | ($25.37M) | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | ($23.88M) | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | ($19.77M) | Apr 27, 2023 |
| FY2021 | Aug 31, 2021 | ($19.74M) | Dec 13, 2021 |
| FY2021 | Aug 31, 2020 | ($18.78M) | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | ($14.14M) | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | ($16.72M) | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | ($9.11M) | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | ($2.43M) | Dec 21, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $6.6K | Apr 18, 2024 |
| FY2023 | Dec 31, 2022 | $24.4K | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | $148.2K | Apr 27, 2023 |
| FY2021 | Aug 31, 2021 | $11.2K | Dec 13, 2021 |
| FY2021 | Aug 31, 2020 | $126.6K | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | $10.3K | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | $79.8K | Dec 16, 2019 |
| FY2019 | Aug 31, 2017 | $87.2K | Dec 16, 2019 |
| FY2018 | Aug 31, 2016 | $431 | Dec 14, 2018 |
| FY2017 | Aug 31, 2015 | $185.9K | Dec 21, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | 0 | Apr 27, 2023 |
| FY2019 | Aug 31, 2019 | 0 | Dec 16, 2019 |
| FY2019 | Aug 31, 2018 | 0 | Dec 16, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 27, 2023 |
| FY2022 | Aug 31, 2021 | 0 | Apr 27, 2023 |
| FY2019 | Aug 31, 2019 | 0 | Dec 16, 2019 |
| FY2019 | Aug 31, 2018 | 0 | Dec 16, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 11.15M | Apr 21, 2025 |
| FY2024 | Dec 31, 2023 | 10.17M | Apr 21, 2025 |
| FY2023 | Dec 31, 2022 | 9.95M | Apr 18, 2024 |
| FY2022 | Dec 31, 2021 | 8.14M | Apr 27, 2023 |
| FY2021 | Aug 31, 2021 | 246.89M | Dec 13, 2021 |
| FY2021 | Aug 31, 2020 | 194.39M | Dec 13, 2021 |
| FY2020 | Aug 31, 2019 | 78.16M | Dec 18, 2020 |
| FY2019 | Aug 31, 2018 | 42.90M | Dec 16, 2019 |
| FY2018 | Aug 31, 2017 | 26.82M | Dec 14, 2018 |
| FY2017 | Aug 31, 2016 | 2.92M | Dec 21, 2017 |